200 related articles for article (PubMed ID: 683378)
1. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
3. Immunologic mechanisms in malignant melanoma of the skin.
Cochran AJ
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
[No Abstract] [Full Text] [Related]
4. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
[No Abstract] [Full Text] [Related]
5. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
Nifontova TP
Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
[No Abstract] [Full Text] [Related]
7. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
8. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
Char DH
Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic response in patients with melanoma of the skin].
Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
[TBL] [Abstract][Full Text] [Related]
13. [Cellular immunity in patients with melanoma].
Gorodinova VV; Kholenshed A; Babakova SV
Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of leukocyte-dependent antibody activity in melanoma patients.
Hersey P; Edwards A; Murray E; McCarthy WH; Milton GW
J Natl Cancer Inst; 1983 Jul; 71(1):45-53. PubMed ID: 6575208
[TBL] [Abstract][Full Text] [Related]
15. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
16. Cell-mediated immunity in chronic polymorphous light eruptions. Leukocyte migration inhibition assay with irradiated skin as antigen.
Jansén CT; Helander I
Acta Derm Venereol; 1976; 56(2):121-5. PubMed ID: 58520
[TBL] [Abstract][Full Text] [Related]
17. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
18. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
19. Membrane associated antigens of human malignant melanoma. II. Leucocyte migration studies with formalin fixed human melanoma cells.
Suter L; Sorg C; Macher E
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):242-9. PubMed ID: 134542
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]